Medicine
ACD Blood-Pack Units (PL 146 PLASTIC) 493 mg/1.65 g/1.48 g per 67.5 mL injection
ACD Blood-Pack Units (PL 146 PLASTIC) 493 mg/1.65 g/1.48 g per 67.5 mL injection is a prescription medicine containing Anhydrous citric acid, Dextrose and Trisodium for intravenous use, marketed by Fenwal, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Anhydrous citric acid, Dextrose and Trisodium
- Brand
- ACD Blood-Pack Units (PL 146 PLASTIC)
- Strength
- 493 mg/1.65 g/1.48 g per 67.5 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 67.5 mL
- Marketing authorisation holder
- Fenwal
- Manufacturer
- Fenwal
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 March 2007
- Identifiers
- DailyMed set ID ba894daa-688e-4a9e-bd74-e71797f951bbNDC 0942-9001Application BN160918
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 67.5 mL in 1 bag | 0942-9001-01 | Fenwal | 1 March 2007 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Anhydrous citric acid, Dextrose and Trisodium
Clinical summary
Anhydrous citric acid, Dextrose and Trisodium is a fixed-dose combination of an anti-coagulant and a calculi dissolution agent. It is available as injection and solution for extracorporeal and intravenous use. MedsAcross supplies Anhydrous citric acid, Dextrose and Trisodium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Anhydrous citric acid, Dextrose and TrisodiumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Anticoagulant Citrate Dextrose A prescribing information (Citra Labs) · U.S. National Library of Medicine, DailyMed
Need ACD Blood-Pack Units (PL 146 PLASTIC) 493 mg/1.65 g/1.48 g per 67.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.